Dr. Shawn Christopher Radford, MD

Dr. Radford practices at Sinai Hospital of Baltimore in Baltimore, Maryland, part of LifeBridge Health.

Dr. Radford's NPI, 1790995934, was assigned on May 23, 2007. Dr. Radford holds Pennsylvania license MD436294.

Dr. Radford's primary practice is Sinai Hospital of Baltimore, at 2401 West Belvedere Avenue, Baltimore, MD 21215 in Baltimore City. The practice phone is (410) 601-9000.

Dr. Radford's primary practice is Sinai Hospital of Baltimore in Baltimore, Maryland, part of LifeBridge Health. Dr. Radford is also affiliated with University of Maryland Shore Medical Center at Chestertown. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Radford to 13 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Radford practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Radford's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Radford's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 427 Medicare services from Dr. Radford across 4 procedure codes in 2024, for 423 Medicare patients. Medicare paid $58,788 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 423 Medicare patients who saw Dr. Radford in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Radford's median patient age at 57, with 49% women.

In 2024, Dr. Radford wrote 149 Medicare Part D claims for 92 patients. 90% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $216 in total drug cost. In 2023, CMS named 120 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Radford for performance year 2024, reported as part of a group.

CMS Open Payments shows 5 general payments to Dr. Radford from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $107.